Replies to post #6178 on Algernon Pharmaceuticals Inc (AGNPF)

[Money $hot]

On August 2, 2018, Breathtec annonced a LOI to acquire Nash Pharmaceuticals.

On October 9, 2018, Breathtec signed Definitive Agreement to acquire Nash Pharmaceuticals.

On October 16, 2018, Breathtec announced completion of consolidation of shares.

On October 22, 2018, Breathtec announced acquisition of Nash Pharmaceuticals.

Since the consolidation/acqusition:

There has been 36 News Releases to date.

Half you shares went up in smoke (2 for 1 R/S).

Dr. Richard Yost tucked his tail and ran off to Owlstone Medical.

Subsequently, the University of Florida Agreement and FAIMS technology became a Dead Fish



Since the consolidation of shares:

The Company currently has 57,897,356 common shares issued and outstanding. Following the Share Consolidation, the Company will have approximately 28,948,678 common shares issued and outstanding.

- there were approximately 6 million warrants.

- there were approximately 2 million options.

- there were approximately 37 million shares fully diluted.

16 months later (as of February 2020):

- the outstanding shares have TRIPLED! 3X

- the warrants have QUADRUPLED! 4X

- the fully diluted shares have QUINTUPLED! 5X

Check the math! You can't make this shit up!

There remains no revenue at Algernon Pharmaceuticals, and there is absolutely no proof ANY "news release" will trigger a sustainable uptrend.

So this was your question -

Thx Shell/AMG ....would you recommend this a Buy right now to family/friends?

You have followed the Bullrun Capital stories for as long as any of us on these message boards. I would think you don't need anyones advice about pennyland. Knowing how Kal & Klan run their "operations" across the spectrum of pennyland propositions, The only way I'd recommend this or any other Bullrun stock to family/friends is if were guaranteed money (printing press) like the Kal & Klan Family & Friends Plan.

/////AMG